Close Menu

NEW YORK – Medical research charity LifeArc said on Monday that it is providing £5 million ($6.9 million) in funding to the GenOMICC consortium to support the GenOMICC COVID-19 study.

The consortium, which launched the study in May 2020 in partnership with Genomics England, is using genomics to investigate the genetic factors underlying disease severity and to increase understanding about the disease. The researchers are hoping that they'll be able to compare the genomes of people who had severe illness with those who had more manageable symptoms.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.